Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model

Detalhes bibliográficos
Autor(a) principal: Alabarse, Paulo Vinicius Gil
Data de Publicação: 2021
Outros Autores: Silva, Jordana Miranda de Souza, Espírito Santo, Rafaela Cavalheiro do, Oliveira, Marianne Schrader de, Almeida, Andrelise Simões de, Oliveira, Mayara Souza de, Immig, Mônica Luiza, Freitas, Eduarda Correa, Teixeira, Vivian de Oliveira Nunes, Bathurst, Camilla L., Brenol, Claiton Viegas, Filippin, Lidiane Isabel, Young, Stephen Peter, Lora, Priscila Schmidt, Xavier, Ricardo Machado
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/245651
Resumo: There is no consensus for diagnosis or treatment of RA muscle loss. We aimed to investigate metabolites in arthritic mice urine as biomarkers of muscle loss. DBA1/J mice comprised collagen-induced arthritis (CIA) and control (CO) groups. Urine samples were collected at 0, 18, 35, 45, 55, and 65 days of disease and subjected to nuclear magnetic resonance spectroscopy. Metabolites were identified using Chenomx and Birmingham Metabolite libraries. The statistical model used principal component analysis, partial least-squares discriminant analysis, and partial least-squares regression analysis. Linear regression and Fisher’s exact test via the MetaboAnalyst website were performed (VIP-score). Nearly 100 identified metabolites had CIA vs. CO and disease time-dependent differences (p < 0.05). Twenty-eight metabolites were muscle-associated: carnosine (VIPs 2.8 × 102) and succinyl acetone (VIPs 1.0 × 10) showed high importance in CIA vs. CO models at day 65; CIA pair analysis showed histidine (VIPs 1.2 × 102) days 55 vs. 65, histamine (VIPs 1.1 × 102) days 55 vs. 65, and L-methionine (VIPs 1.1 × 102) days 0 vs. 18. Carnosine was fatigue- (0.039) related, creatine was food intake- (−0.177) and body weight- (−0.039) related, and both metabolites were clinical score- (0.093; 0.050) and paw edema- (0.125; 0.026) related. Therefore, muscle metabolic alterations were detected in arthritic mice urine, enabling further validation in RA patient’s urine, targeting prognosis, diagnosis, and monitoring of RA-mediated muscle loss.
id UFRGS-2_66240e3e501ba380efb95f3f6662e850
oai_identifier_str oai:www.lume.ufrgs.br:10183/245651
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Alabarse, Paulo Vinicius GilSilva, Jordana Miranda de SouzaEspírito Santo, Rafaela Cavalheiro doOliveira, Marianne Schrader deAlmeida, Andrelise Simões deOliveira, Mayara Souza deImmig, Mônica LuizaFreitas, Eduarda CorreaTeixeira, Vivian de Oliveira NunesBathurst, Camilla L.Brenol, Claiton ViegasFilippin, Lidiane IsabelYoung, Stephen PeterLora, Priscila SchmidtXavier, Ricardo Machado2022-07-28T04:46:50Z20212075-4426http://hdl.handle.net/10183/245651001146363There is no consensus for diagnosis or treatment of RA muscle loss. We aimed to investigate metabolites in arthritic mice urine as biomarkers of muscle loss. DBA1/J mice comprised collagen-induced arthritis (CIA) and control (CO) groups. Urine samples were collected at 0, 18, 35, 45, 55, and 65 days of disease and subjected to nuclear magnetic resonance spectroscopy. Metabolites were identified using Chenomx and Birmingham Metabolite libraries. The statistical model used principal component analysis, partial least-squares discriminant analysis, and partial least-squares regression analysis. Linear regression and Fisher’s exact test via the MetaboAnalyst website were performed (VIP-score). Nearly 100 identified metabolites had CIA vs. CO and disease time-dependent differences (p < 0.05). Twenty-eight metabolites were muscle-associated: carnosine (VIPs 2.8 × 102) and succinyl acetone (VIPs 1.0 × 10) showed high importance in CIA vs. CO models at day 65; CIA pair analysis showed histidine (VIPs 1.2 × 102) days 55 vs. 65, histamine (VIPs 1.1 × 102) days 55 vs. 65, and L-methionine (VIPs 1.1 × 102) days 0 vs. 18. Carnosine was fatigue- (0.039) related, creatine was food intake- (−0.177) and body weight- (−0.039) related, and both metabolites were clinical score- (0.093; 0.050) and paw edema- (0.125; 0.026) related. Therefore, muscle metabolic alterations were detected in arthritic mice urine, enabling further validation in RA patient’s urine, targeting prognosis, diagnosis, and monitoring of RA-mediated muscle loss.application/pdfengJournal of personalized medicine. Basel. Vol. 11, no. 9 (2021), 837, 24 p.BiomarcadoresCaquexiaMetabolismoArtrite reumatóideRheumatoid arthritisPrecision medicineNMRCIAMetabolomicsCachexiaBiomarkersMetabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) modelEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001146363.pdf.txt001146363.pdf.txtExtracted Texttext/plain83859http://www.lume.ufrgs.br/bitstream/10183/245651/2/001146363.pdf.txtba8df21d54792a9202ff21f820dbc6bbMD52ORIGINAL001146363.pdfTexto completo (inglês)application/pdf5060153http://www.lume.ufrgs.br/bitstream/10183/245651/1/001146363.pdf04eda1337059e92737f7fc5c7c669c86MD5110183/2456512022-07-29 04:51:51.322275oai:www.lume.ufrgs.br:10183/245651Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-07-29T07:51:51Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
title Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
spellingShingle Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
Alabarse, Paulo Vinicius Gil
Biomarcadores
Caquexia
Metabolismo
Artrite reumatóide
Rheumatoid arthritis
Precision medicine
NMR
CIA
Metabolomics
Cachexia
Biomarkers
title_short Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
title_full Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
title_fullStr Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
title_full_unstemmed Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
title_sort Metabolomic biomarker candidates for skeletal muscle loss in the collagen-induced arthritis (CIA) model
author Alabarse, Paulo Vinicius Gil
author_facet Alabarse, Paulo Vinicius Gil
Silva, Jordana Miranda de Souza
Espírito Santo, Rafaela Cavalheiro do
Oliveira, Marianne Schrader de
Almeida, Andrelise Simões de
Oliveira, Mayara Souza de
Immig, Mônica Luiza
Freitas, Eduarda Correa
Teixeira, Vivian de Oliveira Nunes
Bathurst, Camilla L.
Brenol, Claiton Viegas
Filippin, Lidiane Isabel
Young, Stephen Peter
Lora, Priscila Schmidt
Xavier, Ricardo Machado
author_role author
author2 Silva, Jordana Miranda de Souza
Espírito Santo, Rafaela Cavalheiro do
Oliveira, Marianne Schrader de
Almeida, Andrelise Simões de
Oliveira, Mayara Souza de
Immig, Mônica Luiza
Freitas, Eduarda Correa
Teixeira, Vivian de Oliveira Nunes
Bathurst, Camilla L.
Brenol, Claiton Viegas
Filippin, Lidiane Isabel
Young, Stephen Peter
Lora, Priscila Schmidt
Xavier, Ricardo Machado
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Alabarse, Paulo Vinicius Gil
Silva, Jordana Miranda de Souza
Espírito Santo, Rafaela Cavalheiro do
Oliveira, Marianne Schrader de
Almeida, Andrelise Simões de
Oliveira, Mayara Souza de
Immig, Mônica Luiza
Freitas, Eduarda Correa
Teixeira, Vivian de Oliveira Nunes
Bathurst, Camilla L.
Brenol, Claiton Viegas
Filippin, Lidiane Isabel
Young, Stephen Peter
Lora, Priscila Schmidt
Xavier, Ricardo Machado
dc.subject.por.fl_str_mv Biomarcadores
Caquexia
Metabolismo
Artrite reumatóide
topic Biomarcadores
Caquexia
Metabolismo
Artrite reumatóide
Rheumatoid arthritis
Precision medicine
NMR
CIA
Metabolomics
Cachexia
Biomarkers
dc.subject.eng.fl_str_mv Rheumatoid arthritis
Precision medicine
NMR
CIA
Metabolomics
Cachexia
Biomarkers
description There is no consensus for diagnosis or treatment of RA muscle loss. We aimed to investigate metabolites in arthritic mice urine as biomarkers of muscle loss. DBA1/J mice comprised collagen-induced arthritis (CIA) and control (CO) groups. Urine samples were collected at 0, 18, 35, 45, 55, and 65 days of disease and subjected to nuclear magnetic resonance spectroscopy. Metabolites were identified using Chenomx and Birmingham Metabolite libraries. The statistical model used principal component analysis, partial least-squares discriminant analysis, and partial least-squares regression analysis. Linear regression and Fisher’s exact test via the MetaboAnalyst website were performed (VIP-score). Nearly 100 identified metabolites had CIA vs. CO and disease time-dependent differences (p < 0.05). Twenty-eight metabolites were muscle-associated: carnosine (VIPs 2.8 × 102) and succinyl acetone (VIPs 1.0 × 10) showed high importance in CIA vs. CO models at day 65; CIA pair analysis showed histidine (VIPs 1.2 × 102) days 55 vs. 65, histamine (VIPs 1.1 × 102) days 55 vs. 65, and L-methionine (VIPs 1.1 × 102) days 0 vs. 18. Carnosine was fatigue- (0.039) related, creatine was food intake- (−0.177) and body weight- (−0.039) related, and both metabolites were clinical score- (0.093; 0.050) and paw edema- (0.125; 0.026) related. Therefore, muscle metabolic alterations were detected in arthritic mice urine, enabling further validation in RA patient’s urine, targeting prognosis, diagnosis, and monitoring of RA-mediated muscle loss.
publishDate 2021
dc.date.issued.fl_str_mv 2021
dc.date.accessioned.fl_str_mv 2022-07-28T04:46:50Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/245651
dc.identifier.issn.pt_BR.fl_str_mv 2075-4426
dc.identifier.nrb.pt_BR.fl_str_mv 001146363
identifier_str_mv 2075-4426
001146363
url http://hdl.handle.net/10183/245651
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Journal of personalized medicine. Basel. Vol. 11, no. 9 (2021), 837, 24 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/245651/2/001146363.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/245651/1/001146363.pdf
bitstream.checksum.fl_str_mv ba8df21d54792a9202ff21f820dbc6bb
04eda1337059e92737f7fc5c7c669c86
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801225062723878912